-
Idera Pharmaceuticals Enters into a Clinical Development Support Agreement with Pillar Partners Foundation
Post on 4/16/18
-
Mylan Partners with Fujifilm Kyowa Kirin Biologics
Post on 4/11/18
-
Helius Medical Technologies Announces Uplisting to Nasdaq and Pricing of Public Offering of Class A Common Stock
Post on 4/11/18
-
Mylan Strengthens Its Capital Structure by Extending Its Debt Maturities with a Successful $1.5 Billion Bond Offering
Post on 4/8/18
-
GNC Announces Plans to Expand into Australia
Post on 4/5/18
-
Windtree Therapeutics Announces Closing of $2.6 Million Private Placement
Post on 4/4/18
-
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post on 4/3/18
-
Idera Pharmaceuticals Files Definitive Proxy Statement in Connection with Pending Merger with BioCryst Pharmaceuticals
Post on 4/2/18
-
Better Buy: Celgene Corporation vs. Gilead Sciences
Post on 4/2/18
-
Alamo Pharma Services Partners with Thingee Corp.
Post on 3/27/18
-
Forbes Magazine Names CSL Limited Among Top 50 Employers in the World
Post on 3/20/18
-
Interview with Chris Cashman, Chairman and CEO of Marinus Pharmaceuticals - Part III
Post on 3/27/18
-
Interview with Chris Cashman, Chairman and CEO of Marinus Pharmaceuticals - Part II
Post on 3/21/18
-
Interview with Chris Cashman, Chairman and CEO of Marinus Pharmaceuticals - Part I
Post on 3/16/18
-
Windtree and Eleison Announce Collaboration
Post on 3/12/18
-
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post on 3/6/18
-
Onconova Therapeutics Announces License Agreement with Pint Pharma
Post on 3/5/18
-
Celgene: Parsing The Ozanimod Debacle
Post on 3/5/18
-
Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post on 3/2/18
-
Genesis HealthCare Regains Compliance With NYSE Continued Listing Standard
Post on 3/1/18
-
Alamo Pharma Services Recognized by Training Magazine asa 2018 Training Top 125 Winner
Post on 2/28/18
-
PhaseBio Awarded $2.8 Million NIH SBIR Grant
Post on 2/27/18
-
Centric Bank Announces Exclusive Practice Financing Partnership with the Pennsylvania Dental Association
Post on 2/26/18
-
Genesis Announces New Financing Commitments and Provides Updates to Previously Announced Restructuring Plans
Post on 2/21/18
-
Celgene's Otezla-Colitis Story; Implications For Other Biotechs
Post on 2/20/18
